TC
THC icon

Taika Capital’s Tenet Healthcare THC Stock Holding History

Taika Capital’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,944
Closed -$498K – 67
2024
Q4 		$498K Buy
+3,944
New +$586K 0.38% 52

Other funds holding THC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Taika Capital's THC Position: Q1 2025 in Review

Taika Capital sold out of Tenet Healthcare (THC) in Q1 2025, closing a stake of 3,944 shares — an estimated $498K sold.

Taika Capital first reported a position in THC in Q4 2024 and held it in 1 quarter. The position peaked at $498K in Q4 2024. 566 funds tracked by Wall St. Rank hold THC as of Q1 2025.

  • Taika Capital reported no remaining Tenet Healthcare position as of Q1 2025 after selling out during the quarter.
  • Taika Capital sold 3,944 Tenet Healthcare shares in Q1 2025, an estimated $498K.
  • Taika Capital first reported a position in Tenet Healthcare in Q4 2024 and held it in 1 quarter.
  • Taika Capital's Tenet Healthcare position peaked at $498K in Q4 2024.
  • 566 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2025.

Based on Taika Capital's 13F filing for Q1 2025.